The Kava Anxiety Depression Spectrum Study (Kadss): A Randomized, Placebo-Controlled Crossover Trial Using An Aqueous Extract Of Piper Methysticum
UTSePress Research/Manakin Repository
JavaScript is disabled for your browser. Some features of this site may not work without it.
- UTSePress Research Home
- >
- 11 Medical and Health Sciences
- >
- Journal Articles
- >
- Closed
- >
- View Item
| dc.contributor.author | Sarris J | en_US |
| dc.contributor.author | Kavanagh Dj | en_US |
| dc.contributor.author | Byrne G | en_US |
| dc.contributor.author | Bone Km | en_US |
| dc.contributor.author | Adams Jon | en_US |
| dc.contributor.author | Deed G | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2012-02-10T06:09:37Z | |
| dc.date.available | 2012-02-10T06:09:37Z | |
| dc.date.issued | 2009 | en_US |
| dc.identifier | 2010003354 | en_US |
| dc.identifier.citation | Sarris J et al. 2009, 'The Kava Anxiety Depression Spectrum Study (Kadss): A Randomized, Placebo-Controlled Crossover Trial Using An Aqueous Extract Of Piper Methysticum', Springer, vol. 205, no. 3, pp. 399-407. | en_US |
| dc.identifier.issn | 0033-3158 | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/17077 | |
| dc.description.abstract | Rationale Piper methysticum (Kava) has been withdrawn in European, British, and Canadian markets due to concerns over hepatotoxic reactions. The WHO recently recommended research into aqueous extracts of Kava. Objective The objective of this study was to | en_US |
| dc.language | en_US | |
| dc.publisher | Springer | en_US |
| dc.relation.isbasedon | http://dx.doi.org/10.1007/s00213-009-1549-9 | en_US |
| dc.title | The Kava Anxiety Depression Spectrum Study (Kadss): A Randomized, Placebo-Controlled Crossover Trial Using An Aqueous Extract Of Piper Methysticum | en_US |
| dc.parent | Psychopharmacology | en_US |
| dc.journal.volume | 205 | en_US |
| dc.journal.number | 3 | en_US |
| dc.publocation | New York | en_US |
| dc.identifier.startpage | 399 | en_US |
| dc.identifier.endpage | 407 | en_US |
| dc.cauo.name | NMH.Faculty of Nursing, Midwifery and Health | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 111500 | en_US |
| dc.personcode | 0000068322;0000065721;0000068323;0000068324;112076;0000068325 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Pharmacology and Pharmaceutical Sciences | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | ISI:000268120400005 | en_US |
| dc.description.keywords | In-Vitro; Disorder; Metaanalysis; Efficacy; Benzodiazepines; Kavalactones; Inventory; Toxicity; Mood | en_US |
| dc.staffid | en_US |
